Xtant Medical Holdings, Inc. (XTNT)

NYSEAMERICAN: XTNT · IEX Real-Time Price · USD
0.515
-0.005 (-0.92%)
At close: Aug 5, 2022 4:00 PM
0.522
+0.007 (1.398%)
After-hours: Aug 8, 2022 8:00 PM EDT
-0.92%
Market Cap 44.97M
Revenue (ttm) 55.98M
Net Income (ttm) -8.01M
Shares Out 87.31M
EPS (ttm) -0.09
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 26,079
Open 0.535
Previous Close 0.520
Day's Range 0.510 - 0.537
52-Week Range 0.450 - 1.360
Beta 1.03
Analysts Sell
Price Target n/a
Earnings Date Aug 4, 2022

About XTNT

Xtant Medical Holdings, Inc. develops, manufactures, and markets regenerative medicine products and medical devices for orthopedic and neurological surgeons in the United States and internationally. Its biomaterial products include OsteoSponge that provides a natural scaffold for cellular in-growth and exposes bone-forming proteins to the healing environment; OsteoSponge SC that fills bony defects in the subchondral region of joints; OsteoSelect DBM Putty for osteoinductive bone growth; OsteoSelect PLUS DBM Putty for use as a bone void filler a... [Read more...]

Industry Health Care Equipment & Supplies
CEO Sean Browne
Employees 116
Stock Exchange NYSEAMERICAN
Ticker Symbol XTNT
Full Company Profile

Financial Performance

In 2021, XTNT's revenue was $55.26 million, an increase of 3.61% compared to the previous year's $53.34 million. Losses were -$4.85 million, -30.96% less than in 2020.

Financial Statements

Analyst Forecast

No stock price forecast available yet.

Price Target
n/a
Analyst Consensus: Sell
Stock Forecasts

News

Xtant Medical Announces Second Quarter 2022 Financial Results

BELGRADE, Mont., Aug. 04, 2022 (GLOBE NEWSWIRE) -- Xtant Medical Holdings, Inc. (NYSE American: XTNT), a global medical technology company focused on surgical solutions for the treatment of spinal disor...

Xtant Medical to Issue Second Quarter 2022 Financial Results on August 4, 2022

BELGRADE, Mont., July 28, 2022 (GLOBE NEWSWIRE) -- Xtant Medical Holdings, Inc. (NYSE American: XTNT), a global medical technology company focused on surgical solutions for the treatment of spinal disor...

Xtant Medical Announces First Quarter 2022 Financial Results

BELGRADE, Mont., May 05, 2022 (GLOBE NEWSWIRE) -- Xtant Medical Holdings, Inc. (NYSE American: XTNT), a global medical technology company focused on surgical solutions for the treatment of spinal disord...

Xtant Medical Appoints Scott Neils as Chief Financial Officer

BELGRADE, Mont., May 02, 2022 (GLOBE NEWSWIRE) -- Xtant Medical Holdings, Inc. (NYSE American: XTNT), a global medical technology company focused on surgical solutions for the treatment of spinal disord...

Xtant Medical to Issue First Quarter 2022 Financial Results on May 5, 2022

BELGRADE, Mont., April 28, 2022 (GLOBE NEWSWIRE) -- Xtant Medical Holdings, Inc. (NYSE American: XTNT), a global medical technology company focused on surgical solutions for the treatment of spinal diso...

Xtant Medical to Present at the Canaccord Musculoskeletal Conference on March 22, 2022

BELGRADE, Mont., March 15, 2022 (GLOBE NEWSWIRE) -- Xtant Medical Holdings, Inc. (NYSE American: XTNT), a global medical technology company focused on surgical solutions for the treatment of spinal diso...

Xtant Medical Announces Fourth Quarter and Full Year 2021 Financial Results

BELGRADE, Mont., March 08, 2022 (GLOBE NEWSWIRE) -- Xtant Medical Holdings, Inc. (NYSE American: XTNT), a global medical technology company focused on surgical solutions for the treatment of spinal diso...

Xtant Medical to Issue Fourth Quarter and Full Year 2021 Financial Results on March 8, 2022

BELGRADE, Mont., March 01, 2022 (GLOBE NEWSWIRE) -- Xtant Medical Holdings, Inc. (NYSE American: XTNT), a global medical technology company focused on surgical solutions for the treatment of spinal diso...

Xtant Medical Appoints Scott Neils Interim Chief Financial Officer

BELGRADE, Mont., Jan. 03, 2022 (GLOBE NEWSWIRE) -- Xtant Medical Holdings, Inc. (NYSE American: XTNT), a global medical technology company focused on surgical solutions for the treatment of spinal disor...

Xtant Medical Announces Third Quarter 2021 Financial Results

BELGRADE, Mont., Nov. 12, 2021 (GLOBE NEWSWIRE) -- Xtant Medical Holdings, Inc. (NYSE American: XTNT), a global medical technology company focused on surgical solutions for the treatment of spinal disor...

Xtant Medical to Issue Third Quarter 2021 Financial Results on November 12, 2021

BELGRADE, Mont., Nov. 05, 2021 (GLOBE NEWSWIRE) -- Xtant Medical Holdings, Inc. (NYSE American: XTNT), a global medical technology company focused on surgical solutions for the treatment of spinal disor...

Xtant Medical Announces Second Quarter 2021 Financial Results

BELGRADE, Mont., Aug. 05, 2021 (GLOBE NEWSWIRE) -- Xtant Medical Holdings, Inc. (NYSE American: XTNT), a global medical technology company focused on surgical solutions for the treatment of spinal disor...

Xtant Medical to Present at the Canaccord Musculoskeletal Conference

BELGRADE, Mont., May 13, 2021 (GLOBE NEWSWIRE) -- Xtant Medical Holdings, Inc. (NYSE American: XTNT), a global medical technology company focused on surgical solutions for the treatment of spinal disord...

Xtant Medical Announces First Quarter 2021 Financial Results

BELGRADE, Mont., May 11, 2021 (GLOBE NEWSWIRE) -- Xtant Medical Holdings, Inc. (NYSE American: XTNT), a global medical technology company focused on surgical solutions for the treatment of spinal disord...

Xtant Medical Files $150 Million Shelf Registration Statement

BELGRADE, Mont., May 11, 2021 (GLOBE NEWSWIRE) -- Xtant Medical Holdings, Inc. (NYSE American: XTNT), a global medical technology company focused on surgical solutions for the treatment of spinal disord...

Xtant Medical Announces $20 Million Debt Financing with MidCap Financial

BELGRADE, Mont., May 06, 2021 (GLOBE NEWSWIRE) -- Xtant Medical Holdings, Inc. (NYSE American: XTNT), a global medical technology company focused on surgical solutions for the treatment of spinal disord...

Xtant Medical to Issue First Quarter 2021 Financial Results on May 11, 2021

BELGRADE, Mont., May 04, 2021 (GLOBE NEWSWIRE) -- Xtant Medical Holdings, Inc. (NYSE American: XTNT), a global medical technology company focused on surgical solutions for the treatment of spinal disord...

Xtant Medical Comments on Trading Activity of its Stock

BELGRADE, Mont., Feb. 26, 2021 (GLOBE NEWSWIRE) -- Xtant Medical Holdings, Inc. (NYSE American: XTNT, the “Company”), a global medical technology company focused on surgical solutions for the treatment ...

XTNT Stock: 7 Things to Know About Xtant Medical as Shares Rocket 150%

Xtant Medical (XTNT) stock is surging higher Friday and InvestorPlace has everything potential investors need to know about the company. The post XTNT Stock: 7 Things to Know About Xtant Medical as Shar...

Xtant Medical Announces Fourth Quarter and Full Year 2020 Financial Results

BELGRADE, Mont., Feb. 24, 2021 (GLOBE NEWSWIRE) -- Xtant Medical Holdings, Inc. (NYSE American: XTNT), a global medical technology company focused on surgical solutions for the treatment of spinal disor...

Xtant Medical Announces $20 Million Private Placement

BELGRADE, Mont., Feb. 22, 2021 (GLOBE NEWSWIRE) -- Xtant Medical Holdings, Inc. (NYSE American: XTNT) (the Company), a global medical technology company focused on surgical solutions for the treatment o...

Xtant Medical to Issue Fourth Quarter and Full Year 2020 Financial Results and Host Conference Call on February 24, 2021

BELGRADE, Mont., Feb. 17, 2021 (GLOBE NEWSWIRE) -- Xtant Medical Holdings, Inc. (NYSE American: XTNT), a global medical technology company focused on surgical solutions for the treatment of spinal disor...

Xtant Medical Announces Expiration of Rights Offering

BELGRADE, Mont., Dec. 07, 2020 (GLOBE NEWSWIRE) -- Xtant Medical Holdings, Inc. (NYSE American: XTNT), a global medical technology company focused on surgical solutions for the treatment of spinal disor...

Xtant Medical Announces Third Quarter 2020 Financial Results

BELGRADE, Mont., Oct. 29, 2020 (GLOBE NEWSWIRE) -- Xtant Medical Holdings, Inc. (NYSE American: XTNT), a global medical technology company focused on surgical solutions for the treatment of spinal disor...

Xtant Medical Announces Record Date and Other Key Dates for Proposed $15 Million Rights Offering

BELGRADE, Mont., Oct. 22, 2020 (GLOBE NEWSWIRE) -- Xtant Medical Holdings, Inc. (NYSE American: XTNT), a global medical technology company focused on surgical solutions for the treatment of spinal disor...